APO2 ligand: a novel lethal weapon against malignant glioma? (Q28272697)

0 references

U Naumann

0 references

T Glaser

0 references

A Ashkenazi

0 references

M Weller

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

0 references

language of work or name

English

0 references

publication date

1 May 1998

0 references

published in

FEBS Letters

0 references

volume

427

0 references

issue

0 references

page(s)

124-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

The receptor for the cytotoxic ligand TRAIL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

A novel receptor for Apo2L/TRAIL contains a truncated death domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Lethal effect of the anti-Fas antibody in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900409-8